SCHEMBL21881772

SCHEMBL21881772

CP(C)(=O)c1ccc(-c2cc(-c3ccc4ccccc4c3)cc(-c3nc(-c4ccccc4)nc(-c4ccc5ccccc5c4)n3)c2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.41
ALDH1A1 P00352 2/20 0.41
KMT2A Q03164 2/20 0.41
KDM4E B2RXH2 1/20 0.41
TP53 P04637 1/20 0.41
CYP1A2 P05177 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
HSD17B10 Q99714 1/20 0.41
CYP11B1 P15538 2/20 0.39
CYP11B2 P19099 2/20 0.39
ESR1 P03372 3/20 0.38
ESR2 Q92731 3/20 0.38
CYP17A1 P05093 1/20 0.38
CYP19A1 P11511 1/20 0.38
SIRT2 Q8IXJ6 4/20 0.38
CA1 P00915 1/20 0.37
CA2 P00918 1/20 0.37
CA9 Q16790 1/20 0.37
ADORA2A P29274 1/20 0.37
ADORA1 P30542 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21881771 0.90 CYP1A1 (0.47) MEN1ALDH1A1KMT2AKDM4ETP53
SCHEMBL21881751 0.89 L3MBTL1 (0.43) MEN1ALDH1A1KMT2AKDM4EL3MBTL1
SCHEMBL21881892 0.88 MEN1 (0.39) MEN1ALDH1A1KMT2AKDM4ETP53
SCHEMBL26154639 0.85 MEN1 (0.53) MEN1ALDH1A1KMT2AKDM4ETP53
SCHEMBL21881901 0.85 SIRT2 (0.43) MEN1ALDH1A1KMT2AKDM4ETP53
SCHEMBL26572202 0.84 MEN1 (0.51) MEN1ALDH1A1KMT2AKDM4ETP53
SCHEMBL23633603 0.84 MEN1 (0.54) MEN1ALDH1A1KMT2AKDM4ETP53
SCHEMBL21881780 0.84 L3MBTL1 (0.50) MEN1ALDH1A1KMT2AKDM4ESMN1; SMN2
SCHEMBL19533268 0.84 MEN1 (0.54) MEN1ALDH1A1KMT2AKDM4ETP53
SCHEMBL18878253 0.84 MEN1 (0.54) MEN1ALDH1A1KMT2AKDM4ETP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11795186-B2 Organic electronic device comprising an organic semiconductor layer and a device NOVALED GMBH (DE) 2023-10-24 US disclosed
US-11795186-B2 Organic electronic device comprising an organic semiconductor layer and a device NOVALED GMBH (DE) 2023-10-24 US disclosed
US-20200095269-A1 Organic Electronic Device Comprising an Organic Semiconductor Layer and a Device NOVALED GMBH (DE) 2020-03-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200095269-A1 Organic Electronic Device Comprising an Organic Semiconductor Layer and a Device C1S, C1R, CCNA1 MEN1 762/4885ALDH1A1 887/4885KMT2A 3297/4885
US-11795186-B2 Organic electronic device comprising an organic semiconductor layer and a device C1S, C1R, CCNA1 MEN1 762/4885ALDH1A1 887/4885KMT2A 3297/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.